Brief Summary
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.
Protocol Interventions
Drug: TORL-1-23, Drug: Pegfilgrastim (drug)
- Make an AppointmentAppointments
Make an Appointment
Let Siteman's care coordinators guide you through your next best step. Their oncology expertise means you are in good hands.Start with Siteman
Talk With Us
Currently in Treatment at Siteman